Chile First South American Nation to Eliminate Dog-Transmitted Rabies
According to official announcements from the WHO, the milestone marks more than five decades without a reported case of dog-to-human rabies transmission, anchoring a historic achievement built on sustained epidemiological surveillance, widespread animal vaccination, and rapid clinical intervention.
- Chile is officially validated by the WHO as the first South American country to eliminate dog-transmitted rabies.
- The last documented case of dog-to-human transmission in the country occurred in 1972, according to the WHO.
- The eradication was achieved through an ongoing National Rabies Prevention and Control Programme combining mass pet immunization, door-to-door dog vaccination campaigns, and timely post-exposure prophylaxis.
Epidemiological Milestone and the 1972 Baseline
The formal recognition highlights a long-term public health effort that effectively halted the circulation of the rabies virus among domestic canine populations. According to data released by the World Health Organization, Chile’s last reported human case of dog-mediated rabies occurred in 1972. Maintaining a span of over fifty years without human casualties from canine vectors required rigorous epidemiological oversight and continuous risk mitigation.
Once clinical symptoms manifest, the pathology is almost always fatal. However, transmission from domestic dogs to humans remains entirely preventable through targeted veterinary interventions, robust surveillance, and immediate medical access to post-exposure prophylaxis following animal bites or scratches.
Multi-Tiered Prevention and Public Policy Implementation
The successful eradication model relied heavily on a coordinated national framework executed across multiple levels of government and healthcare infrastructure. According to statements from Chilean Health Minister May Chomali, the milestone stems from joint efforts involving local municipalities, dedicated zoonosis teams, and active community participation. These localized operations form the foundation of Chile’s National Rabies Prevention and Control Programme.

Operational components of the national program include:
- Free mass vaccination campaigns targeting domestic dogs and cats.
- Door-to-door canine immunization drives coordinated by municipal workers.
- Targeted dog population management and community education initiatives.
- Strengthened laboratory diagnostic capacity for monitoring virus circulation in animal reservoirs.
- Proactive risk assessment and preventive vaccination protocols deployed in high-risk border zones.
WHO Director-General Dr. Tedros Adhanom Ghebreyesus noted in a public statement that the validation reflects decades of commitment to protecting communities and demonstrates the tangible impact of sustained public health investments. Complementing this, Pan American Health Organization (PAHO) Director Dr. Jarbas Barbosa emphasized that regional cooperation and robust cross-sector investments in vaccination and surveillance are essential for rendering such health targets achievable.

Securing official WHO validation requires more than a passive absence of disease. Sovereign health authorities must submit an exhaustive technical dossier proving that national infrastructure possesses active systems capable of preventing re-emergence. An independent international expert group convened by PANAFTOSA, PAHO, and the WHO reviewed Chile’s submission, confirming compliance with international standards for laboratory diagnostics, animal vaccination coverage, and rapid clinical response.
For patients presenting with potential exposure to suspected rabid animals, immediate clinical triage remains vital. Healthcare facilities must maintain strict adherence to standardized post-exposure protocols.
As regional programs continue to drive down human rabies cases across the Americas—dropping by more than 98% since 1983, according to PAHO figures—Chile’s framework provides a replicable blueprint for nations working to eradicate vaccine-preventable zoonotic threats.
*Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.*